May 28: The Week in Cancer News
A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and more news of the week from Cancer Today.
Progress Against Cancer
A study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and more news of the week from Cancer Today.
The FDA has granted accelerated approval to a molecularly targeted therapeutic along with a companion diagnostic to treat certain patients with cholangiocarcinoma. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to...
Melanoma is an aggressive form of skin cancer. While it is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly due to its tendency to...
The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and more news of the week from Cancer Today.
The FDA granted accelerated approval to the first targeted therapeutic and a companion diagnostic for certain adult patients with non-small cell lung cancer that tests positive for specific mutations in a protein that helps...
The FDA has approved an immunotherapeutic for certain patients with these cancers who had their cancer completely resected and received chemoradiotherapy before surgery. The U.S. Food and Drug Administration (FDA) approved the immunotherapeutic nivolumab...
Study suggests ovarian cancer screening does not reduce mortality, and more news of the week from Cancer Today.
Since 2014, the American Association for Cancer Research (AACR) has invited early-career investigators to apply to the NextGen Stars program, which provides awardees the opportunity to present their research on a global stage at the AACR Annual Meeting. The enhanced visibility granted by the NextGen Stars program has...
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and more news of the week from Cancer Today.
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells (giving rise to myeloma). In 2020 alone, there were an estimated 1.3 million new blood cancer cases worldwide, which accounted for more than 5 percent of all cancer diagnoses that...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More